|
Boots
Piramal to launch Optrex in India; rejigs sales force
Fast moving health goods (FMHG) major Boots Piramal Healthcare Ltd
(BPHL) is likely to introduce its parent Boots Healthcare Internationals
(BHI) eye care brand Optrex shortly in India
Orchids
anti-diabetic molecule to enter phase II in April 04
City-based Orchid Chemicals and Pharmaceuticals Ltds new anti-diabetic
molecule BL1002 presently undergoing phase one global trials under
its US partner Bexel Pharma will enter the next phase in April next
year
Lotus
sets up pathology laboratory
IN an effort to consolidate its activities as one of the leading
CROs, the Bangalore based Lotus Labs Pvt Ltd is setting up a new
pathology laboratory offering services in the areas of biochemistry,
pathology and microbiology.
Suresh
Prabhu, NPIL to tackle spurious drugs menace
IN ORDER to create awareness and tackle the menace of spurious drugs
effectively, the government has assigned former Union Minister Suresh
Prabhu who would undertake massive programme in this direction along
with Harinder Sikka, senior vice-president, Nicholas Piramal India
Ltd (NPIL)and chairman CII Task Force
Unichem
releases results of LORD trial with Loram
THE growing population of diabetes and hypertensive patients in
India can reduce the chances of heart attack dramatically by controlling
their blood pressure effectively
|